BIC
GILD icon

Bridges Investment Counsel’s Gilead Sciences GILD Stock Holding History

Bridges Investment Counsel’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$558K Sell
7,778
-650
-8% -$49.4K 0.31% 80
2017
Q3 		$682K Sell
8,428
-19,563
-70% -$1.5M 0.38% 69
2017
Q2 		$1.98M Buy
27,991
+9,302
+50% +$619K 0.45% 65
2017
Q1 		$1.27M Buy
18,689
+6,875
+58% +$483K 0.37% 61
2016
Q4 		$846K Sell
11,814
-16,236
-58% -$1.21M 0.21% 96
2016
Q3 		$2.22M Sell
28,050
-75
-0.3% -$6.09K 0.47% 64
2016
Q2 		$2.35M Buy
28,125
+1,110
+4% +$98.5K 0.52% 59
2016
Q1 		$2.48M Sell
27,015
-9,630
-26% -$868K 0.54% 54
2015
Q4 		$4.29M Hold
36,645
– – 0.74% 35
2015
Q3 		$4.29M Buy
36,645
+16,768
+84% +$1.86M 0.74% 35
2015
Q2 		$2.33M Buy
19,877
+3,275
+20% +$358K 0.55% 60
2015
Q1 		$1.63M Hold
16,602
– – 0.37% 74
2014
Q4 		$1.56M Buy
16,602
+225
+1% +$23.3K 0.36% 74
2014
Q3 		$1.74M Sell
16,377
-250
-2% -$24.5K 0.4% 69
2014
Q2 		$1.38M Buy
16,627
+2,085
+14% +$162K 0.32% 80
2014
Q1 		$1.03M Buy
14,542
+11,045
+316% +$866K 0.24% 93
2013
Q4 		$263K Buy
+3,497
New +$243K 0.06% 149

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bridges Investment Counsel's GILD Position: Q4 2017 in Review

Bridges Investment Counsel reduced its Gilead Sciences (GILD) stake by 7.7% in Q4 2017, selling an estimated $49.4K and leaving 7,778 shares worth $558K. The position accounts for 0.31% of the portfolio, ranked #80.

Bridges Investment Counsel first reported a position in GILD in Q4 2013 and has held it in 17 quarters since. The position peaked at $4.29M in Q4 2015. 1,575 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • Bridges Investment Counsel held 7,778 shares of Gilead Sciences worth $558K as of Q4 2017.
  • Bridges Investment Counsel sold 650 Gilead Sciences shares in Q4 2017, an estimated $49.4K.
  • Gilead Sciences made up 0.31% of Bridges Investment Counsel's portfolio in Q4 2017, its #80 holding.
  • Bridges Investment Counsel first reported a position in Gilead Sciences in Q4 2013 and has held it in 17 quarters since.
  • Bridges Investment Counsel's Gilead Sciences position peaked at $4.29M in Q4 2015.
  • 1,575 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Bridges Investment Counsel's 13F filing for Q4 2017, filed 9 Feb 2018.